A vital component of our blood is hemoglobin. The protein in red blood cells is responsible for carrying carbon dioxide back to the lungs for expiration and oxygen from the lungs to the rest of the body. The illness is called anemia when hemoglobin levels fall. Because the body finds it difficult to get the oxygen it needs, it is normal to feel weak, exhausted, or short of breath when anemic. Although anemia can be caused by a variety of factors, such as chronic illnesses or dietary deficits, it is also commonly linked to specific cancers. Low hemoglobin levels can also occasionally be among the first indications that something more dangerous is occurring within the body.
Low hemoglobin can be caused directly or indirectly by a number of cancer forms. A variety of mechanisms may contribute to this relationship: some cancers result in chronic inflammation that impairs the production of red blood cells, while others cause blood loss or interfere with bone marrow function. A closer examination of the cancer types most frequently associated with low hemoglobin levels as well as the biological mechanisms underlying these relationships is necessary to comprehend how cancer might result in anemia.
In gastrointestinal tract tumors, there is one of the strongest correlations between low hemoglobin and cancer. These consist of esophagus, stomach, and colon cancers. Over time, these tumors may result in gradual, frequently undetectable internal bleeding. Blood loss may not always be apparent; it can happen as microscopic bleeding that is not discovered by laboratory testing or as hidden blood in the stool. Hemoglobin levels gradually decline as a result of this ongoing blood loss, frequently resulting in iron-deficiency anemia. Patients with these tumors might not have any tumor-related symptoms at first, but as the anemia worsens, they might start to feel exhausted, lightheaded, or short of breath. Patients frequently seek medical attention for unexplained anemia, which results in additional testing and a cancer diagnosis.
One of the most prevalent cancers linked to low hemoglobin is colorectal cancer. Bleeding may go undetected for months or even years since it frequently develops slowly and silently. Likewise, ulcers or tumor erosion into the stomach lining may result from gastric cancer, often known as stomach cancer. Although less frequent, esophageal cancer can also bleed and develop into anemia. Low hemoglobin levels in these situations could be the initial clinical indicator that triggers a more thorough assessment.
Anemia can also result from other cancers that affect the bone marrow, the spongy tissue inside bones where blood cells are made, rather than through bleeding. This is especially true for blood malignancies including multiple myeloma, leukemia, and lymphoma. For example, leukemia stops the bone marrow from producing healthy red blood cells because it is overloaded with aberrant white blood cells. Hemoglobin levels consequently fall, frequently considerably. In addition to a variety of additional symptoms associated with poor oxygen supply throughout the body, patients may exhibit extreme weariness and pallor.
Red blood cell production can also be disrupted by lymphomas, particularly Hodgkin’s and non-Hodgkin’s lymphomas. The persistent inflammation linked to these tumors causes anemia of chronic illness, even though they may not directly infiltrate the bone marrow in their early stages. This type of anemia develops when a chronic sickness impairs the body’s capacity to handle iron appropriately and inhibits the signals required for the production of new red blood cells. Iron may not be available for the synthesis of hemoglobin, even if blood levels seem normal or high.
Anemia is a well-known side effect of multiple myeloma, a bone marrow malignancy of plasma cells. By pushing out healthy cells and releasing chemicals that further suppress the generation of red blood cells, the malignant plasma cells disrupt the usual environment of the bone marrow. This raises the risk of kidney failure, immune system compromise, and bone discomfort in addition to lowering hemoglobin levels.
Another cancer that is commonly linked to anemia is lung cancer, especially when it is in a more advanced stage. Here, the relationship is frequently complex. In certain instances, the cancer may spread to the bone marrow or alter the body’s general metabolic process, which would impair the production of new blood cells. In others, the body either stops producing enough red blood cells or begins destroying them more quickly than usual due to the chronic inflammation and metabolic changes brought on by the cancer. Chemotherapy and radiation are two lung cancer treatments that can harm bone marrow and reduce its capacity to produce hemoglobin.
Low hemoglobin levels can also be caused by gynecological cancers, including ovarian, cervical, and uterine cancers, particularly when there is irregular bleeding. For instance, severe or protracted menstrual bleeding may be experienced by women with uterine cancer, which may ultimately lead to iron-deficiency anemia. In a similar vein, bleeding following sexual activity or in between periods may result from cervical cancer, which can gradually deplete the body’s iron reserves and lower hemoglobin levels. Anemia can result from chronic disease mechanisms or as a side effect of chemotherapy, even though ovarian cancer is less likely to cause direct blood loss.
Because the kidneys produce the hormone erythropoietin, which promotes the creation of red blood cells, kidney cancer may be an underlying cause of anemia, even though it is not as frequently discussed in connection with anemia. Anemia can result from the kidneys’ inability to produce enough of this hormone when they are damaged or infiltrated by malignancy. Low hemoglobin can also be caused by malignancies that spread to the kidneys or bones, which can interfere with these essential functions.
Anemia in certain cancers is caused by both the illness and the therapies used to treat it. One of the main causes of low hemoglobin in many cancer patients is chemotherapy. These potent medications target cells that divide quickly, which includes bone marrow-derived blood cells as well as cancer cells. Weakness and exhaustion may arise from a sharp decline in red blood cell production brought on by this collateral damage. Similar results can be obtained via radiation therapy, especially when it targets big bodily parts or bones. Anemia and blood loss can result after even tumor removal surgery, particularly when affecting organs with abundant blood supplies.
In cancer patients, treating low hemoglobin frequently necessitates a multimodal strategy. To encourage the body to make more red blood cells, doctors may recommend erythropoiesis-stimulating drugs, iron supplements, or blood transfusions. Naturally, treating the underlying illness is crucial, but controlling the anemia also enhances physical function, energy levels, and quality of life—all of which are crucial during cancer treatment.
In the context of cancer, low hemoglobin is a symptom that conveys a narrative rather than only being a lab result. It could be a side effect of treatment, the result of a developing tumor, or the first indication that anything is off. Whatever the reason, it needs to be addressed. Knowing which cancers are frequently associated with anemia can help patients and medical professionals identify the illness early, which will speed up diagnosis and improve results.
In the end, hemoglobin and cancer have a complicated and multifaceted interaction. Cancers of the stomach may bleed. Production may be disrupted by blood malignancies. Inflammation may result from solid tumors. Bone marrow function may be suppressed by treatments. Every patient has a different journey, and every situation is different. However, anemia is usually a warning indicator that should be taken seriously. Whether mild or severe, it can provide understanding of the body’s underlying mechanisms and guide the path to more thorough research, prompt diagnosis, and efficient treatment.